Wednesday, December 23, 2015

Drugs: Responding to FDA Investigation Requests


Drugs: Responding to FDA Investigation Requests  | Download Slides
Speakers will discuss FDA requests for information, different situations where inquiries can arise, and steps a company should take during response and investigation, including a company's obligations.

John Manthei, Partner, Latham & Watkins LLP

Gary Messplay, Partner, Hunton & Williams LLP  
Mark Levy, Member, Eckert Seamans Cherin & Mellott, LLC
Moderated by Kay Holcombe, Science Vice President, Science Policy, Biotechnology Industry

-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)